Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseasesnet;Serumska koncentracija faktora nekroze tumora alfa u procjeni aktivnosti inflamatornih bolesti crijeva

Medicinski Glasnik

Volumn 10, Issue 2, 2013, Pages 211-216

  Avdagić, Nesina ^a   Babić, Nermina ^a   Šeremet, Mensura ^b   Delić Šarac, Marina ^b   Drače, Zahida ^b   Denjalić, Amir ^c   Nakaš Ićindić, Emina ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

^c NONE

Author keywords

Crohn's disease; TNF ; Ulcerative colitis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; ENDOSCOPY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; ULCERATIVE COLITIS; BLOOD; INFLAMMATORY BOWEL DISEASE;

BIOMARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880727072     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Friedman S, Blumberg RS. Inflammatory bowel disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's principles of internal medicine, 18th ed. New York: McGraw-Hill, 2011.
2. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
3. Mahajan S, Mehta A. Role of cytokines in pathophysiology of asthma. Iranian Journal of pharmacology and therapeutics 2006; 5:1-14.
4. Feldmann M, Saklatvala J. Proinflammatory cytokines. Cytokine Ref 2001; 1:291-305.
5. Peterson KM, Shu J, Duggal P, Haque R, Mondal D, Petri WA Jr. Association between TNF-α and Entamoeba histolytica Diarrhea. Am J Trop Med Hyg 2010; 82:620-5.
6. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286:G367-76.
7. Rojas-Cartagena C, Flores I, Appleyard CB. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine 2005; 32:85-93.
8. Kuhbacher T, Fölsch UR. Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol 2007; 13:1149-55.
9. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB. Tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37:818-26.
10. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994; 106:960-72.
11. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumor necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32:913-7.
12. Hyams JS, Treem WR, Eddy E, Wyzga N, Moore RE. Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12:233-6.
13. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87:971-6.
14. PA van Hees, PH van Elteren, HJ van Lier, JH van Tongeren. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21:279-86.
15. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339:89-91.
16. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-5.
17. Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, Tsuji Y, Akiyama S, Tsuji N, Niitsu Y. Serum tumor necrosis factor activity in inflammatory bowel disease. Immunopharmacol Immunotoxicol 1992; 14:451-61.
18. Murch SH, Braegger CP, Walker-Smith JA, Mac-Donald TT. Location of tumor necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34:705-9.